---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Absci

🌎 absci.com

Absci is a data-first AI drug creation company that focuses on designing differentiated therapeutics using generative AI. The company utilizes its Integrated Drug Creation platform to develop advanced AI models for drug discovery, particularly targeting difficult-to-drug biologics. Headquartered in Vancouver, Washington, Absci aims to unlock novel biology and enhance the therapeutic potential of proteins through innovative technologies.

---

Absci - Latest News and Updates

• Absci is currently hiring for the position of Director, Alliance & Growth Strategy in the United States.
• Absci will present at the Festival of Biologics on April 23 in the AI and Machine Learning for Drug Discovery track.
• Absci is seeking an experienced accounting leader as it approaches becoming a clinical-stage biotech, according to Todd Bedrick, SVP Chief Accounting Officer.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.